Dexter DT - Search Results

1

Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesis.

Pienaar IS, Dexter DT, Burkhard PR. Pienaar IS, et al. Among authors: dexter dt. Expert Rev Proteomics. 2010 Apr;7(2):205-26. doi: 10.1586/epr.10.8. Expert Rev Proteomics. 2010. PMID: 20377388 Review.

2

Synaptic protein alterations in Parkinson's disease.

Pienaar IS, Burn D, Morris C, Dexter D. Pienaar IS, et al. Mol Neurobiol. 2012 Feb;45(1):126-43. doi: 10.1007/s12035-011-8226-9. Epub 2011 Dec 29. Mol Neurobiol. 2012. PMID: 22205299 Review.

3

An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.

Pienaar IS, Harrison IF, Elson JL, Bury A, Woll P, Simon AK, Dexter DT. Pienaar IS, et al. Among authors: dexter dt. Brain Struct Funct. 2015 Jan;220(1):479-500. doi: 10.1007/s00429-013-0669-5. Epub 2013 Nov 29. Brain Struct Funct. 2015. PMID: 24292256

4

Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease.

Pienaar IS, Lee CH, Elson JL, McGuinness L, Gentleman SM, Kalaria RN, Dexter DT. Pienaar IS, et al. Among authors: dexter dt. Neurobiol Dis. 2015 Feb;74:392-405. doi: 10.1016/j.nbd.2014.12.006. Epub 2014 Dec 19. Neurobiol Dis. 2015. PMID: 25533682 Free article.

5

High resolution and dynamic imaging of biopersistence and bioreactivity of extra and intracellular MWNTs exposed to microglial cells.

Goode AE, Gonzalez Carter DA, Motskin M, Pienaar IS, Chen S, Hu S, Ruenraroengsak P, Ryan MP, Shaffer MS, Dexter DT, Porter AE. Goode AE, et al. Among authors: dexter dt. Biomaterials. 2015 Nov;70:57-70. doi: 10.1016/j.biomaterials.2015.08.019. Epub 2015 Aug 8. Biomaterials. 2015. PMID: 26298523 Free PMC article.

6

Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's disease.

Pienaar IS, Gartside SE, Sharma P, De Paola V, Gretenkord S, Withers D, Elson JL, Dexter DT. Pienaar IS, et al. Among authors: dexter dt. Mol Neurodegener. 2015 Sep 23;10:47. doi: 10.1186/s13024-015-0044-5. Mol Neurodegener. 2015. PMID: 26394842 Free PMC article.

7

DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats.

Sharma PK, Wells L, Rizzo G, Elson JL, Passchier J, Rabiner EA, Gunn RN, Dexter DT, Pienaar IS. Sharma PK, et al. Among authors: dexter dt. Neurotherapeutics. 2020 Jul;17(3):1120-1141. doi: 10.1007/s13311-019-00830-4. Neurotherapeutics. 2020. PMID: 31965550 Free PMC article.

8

Novel 1-hydroxypyridin-2-one metal chelators prevent and rescue ubiquitin proteasomal-related neuronal injury in an in vitro model of Parkinson's disease.

Lewis FW, Fairooz S, Elson JL, Hubscher-Bruder V, Brandel J, Soundararajan M, Smith D, Dexter DT, Tétard D, Pienaar IS. Lewis FW, et al. Among authors: dexter dt. Arch Toxicol. 2020 Mar;94(3):813-831. doi: 10.1007/s00204-020-02672-y. Epub 2020 Feb 20. Arch Toxicol. 2020. PMID: 32078022

9

Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's disease.

Duke DC, Moran LB, Kalaitzakis ME, Deprez M, Dexter DT, Pearce RK, Graeber MB. Duke DC, et al. Among authors: dexter dt. Neurogenetics. 2006 Jul;7(3):139-48. doi: 10.1007/s10048-006-0033-5. Epub 2006 May 13. Neurogenetics. 2006. PMID: 16699787 Free article.

10

Voltage-gated calcium channels and Parkinson's disease.

Hurley MJ, Dexter DT. Hurley MJ, et al. Among authors: dexter dt. Pharmacol Ther. 2012 Mar;133(3):324-33. doi: 10.1016/j.pharmthera.2011.11.006. Epub 2011 Nov 23. Pharmacol Ther. 2012. PMID: 22133841 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page